Skip to content

Bright light therapy in people with a moderate to severe dementia and a depressive disorder

Bright light therapy in people with a moderate to severe dementia and a depressive disorder - Bright light therapy in people with dementia and a depressive disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON41993
Enrollment
80
Registered
2015-10-12
Start date
2016-01-18
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depressive disorder

Interventions

None listed

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * Age: 65 years and older * Diagnosis of dementia. The patient must be diagnosed by a doctor (general practitioner, geriatrician, neurologist, geriatric specialist). * Diagnosis of depression: either major depressive disorder, or limited depression. This diagnosis is made by the (GZ-) psychologist of the nursing home department, according to the Multidisciplinaire Richtlijn Depressie, addendum Ouderen, of Trimbos Instituut, from which the ' Provisional Diagnostic Criteria for Depression in Alzheimer's Disease ' (Olin et al., 2002) are used. The Cornell Scale for Depression in Dementia (CSDD) is used as a screening instrument.

Exclusion criteria

Exclusion criteria: * Other neurological disorders (such as non-congenital brain damage or Korsakov's syndrome, Parkinson and Huntington), except for CVA belonging to vascular dementia. * Other psychiatric disorders (such as bipolar disorder, anxiety disorder or psychosis) * Serious eye conditions (for example, macular degeneration or eye conditions as a result of diabetes), where there is a contraindication to BLT * Sensitivity to light (e.g. as a result of epilepsy) * Highly elevated blood pressure syst > 200 For each participant the doctor of the nursing home department will determine whether BLT is medically justified.

Design outcomes

Primary

MeasureTime frame
-Number of clients that fully completed the BLT treatment protocol -Description of the way the protocol is executed -Frequency and nature of the required adjustments to the protocol -Frequency and nature of side effects

Secondary

MeasureTime frame
Change in level of depressive symptoms.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)